Promising heart drug fails in trial; cardiologists seek cause

A highly anticipated cardiovascular drug failed to prevent heart attacks in a major trial, contradicting strong mechanistic expectations. Cardiologists are investigating potential flaws in trial design or patient selection. The failure may reshape research priorities in cardiovascular prevention.